Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: April 16, 2015
Michael Durheim discusses surrogate endpoints for trials in IPF.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv